# K133856: Powerglide Midline Catheter

- Pathway: 510(k) (Special)
- Applicant: C.R. Bard, Inc.
- Decided: Jan 16, 2014 after 28 days
- Product code: FOZ (Catheter, Intravascular, Therapeutic, Short-Term Less Than 30 Days)
- Device class: 2
- Regulation: 21 CFR 880.5200
- Recalls of this device: 1 (0 Class I)
- Data: FDA decisions to Oct 25, 2026; recalls to Oct 12, 2026

## Lineage
Longest line of descent: 7 generations back to K932323 (1993). 22 ancestors in all.
12 later devices descend from it; 2 cite it directly.
0 of 35 devices in its family (counting itself) have a Class I recall.

## Predicates on the family tree (from the FDA summary)
- K121073: Powerglide Midline Catheter, C.R. Bard, Inc. (2012) Summary page 1.

## Most influential descendants
- K153280: PowerGlide Pro Midline Catheter (2016), 5 descendants of its own
- K150407: BioFlo Midline Catheter (2015), 5 descendants of its own
- K162377: PowerGlide Pro Midline Catheter (2016), 4 descendants of its own
- K203069: HydroMID (2021), 3 descendants of its own
- K220772: HydroMID 4F Single Lumen Midline Catheter (2022), 2 descendants of its own

## Recalls of this device
- Aug 8, 2014 · Class II · Z-1274-2015: Some unit packages of BD PosiFlush SF Saline Flush Syringe 10 mL may exhibit open seals, which could impact product sterility. Bard includes these pouched syringes, attached to some configurations of 

## Indications for use
The PowerGlide® Midline Catheter is inserted into a patient's vascular system for short-term use (<30 days) to sample blood or administer fluids intravenously. These catheters may be used for any patient population with consideration given to adequacy of vascular anatomy and appropriateness of the procedure. The PowerGlide® Midline Catheter is suitable for use with power injectors.

Source page: https://510kreport.com/device/K133856
Methodology: https://510kreport.com/methodology